The University of Illinois at Chicago, Northwestern University, the University of Chicago, and other affiliated hospitals and clinics have been selected to enroll 150,000 Illinoisans in the national Precision Medicine Initiative Cohort Program.
The University of Illinois at Chicago, Northwestern University, the University of Chicago, and other affiliated hospitals and clinics have been selected to enroll 150,000 Illinoisans in the national Precision Medicine Initiative Cohort Program.
Volunteer participants in the Precision Medicine Initiative Cohort Program will be asked to contribute a wide range of health, environment, and lifestyle information. The participants will also answer questions about their health history and status, share their genomic and other biological information through simple blood and urine tests, and grant access to their clinical data from electronic health records.
The knowledge gained from the Precision Medicine Initiative Cohort Program will extend the success of precision medicine in some cancers to many other diseases.
Nurse-Led Program May Increase Germline Testing in Black Veterans With Cancer
June 1st 2023The association between use of a telegenetics service and lower likelihood of germline testing was statistically significant among black veterans with cancer, according to a recent retrospective cohort study.
New NSCLC Treatment Options Needed to Successfully Target Multiple Gene Changes
November 24th 2017Researchers analyzed samples from 1,122 patients with advanced-stage NSCLC and discovered that 92.9% of tumors from harbored multiple changes in cancer-related genes in addition to the EGFR driver mutation.